Healthcare-Life-Sciences Market Reports

Comprehensive industry analysis, market size, and forecast for healthcare-life-sciences.

Showing 261 - 270 of 1045 reports

Vestibular Neuronitis Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.42 Billion Market Size 2034: USD 2.61 Billion CAGR: 6.3% Market Definition: The vestibular neuronitis treatment market encompasses pharmaceuticals, vestibular rehabilitation therapies, and diagnostic services used to manage acute vertigo and balance dysfunction caused by vestibular nerve inflammation. It … Read More
Published June 2026

Vasovagal Syncope Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.82 billion Market Size 2034: USD 3.41 billion CAGR: 6.5% Market Definition: The vasovagal syncope treatment market encompasses pharmacological agents, implantable devices, and non-pharmacological interventions used to prevent and manage reflex-mediated fainting episodes triggered by autonomic nervous system dysfunction. … Read More
Published June 2026

Zollinger Ellison Syndrome Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.84 billion Market Size 2034: USD 3.12 billion CAGR: 5.4% Market Definition: The Zollinger-Ellison Syndrome (ZES) treatment market encompasses pharmaceutical and surgical interventions targeting gastrin-secreting tumors (gastrinomas) and their associated hypersecretory acid conditions. It includes proton pump inhibitors, somatostatin … Read More
Published June 2026

Animal Anti-Rabies Vaccine Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.82 billion Market Size 2034: USD 3.41 billion CAGR: 6.5% Market Definition: The animal anti-rabies vaccine market encompasses biological products designed to immunise domestic animals, livestock, and wildlife against the rabies virus. It includes inactivated, live-attenuated, and recombinant vaccine … Read More
Published June 2026

X-Linked Hypophosphatemia (XLH) Treatment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $1.84 billion Market Size 2034: $4.12 billion CAGR: 8.4% Market Definition: The XLH treatment market encompasses pharmaceutical therapies, including FGF23-inhibiting biologics and conventional phosphate-vitamin D supplementation regimens, used to manage X-Linked Hypophosphatemia, a rare hereditary phosphate-wasting disorder caused by PHEX … Read More
Published June 2026

Biotechnology Contract Manufacturing Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 22.4 billion Market Size 2034: USD 61.8 billion CAGR: 10.7% Market Definition: The biotechnology contract manufacturing market encompasses third-party organisations that produce biologics, cell and gene therapies, vaccines, and related products on behalf of pharmaceutical and biotech companies. Services … Read More
Published June 2026

Pharmaceuticals Packaging Testing Equipment Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.82 billion Market Size 2034: USD 3.47 billion CAGR: 6.7% Market Definition: Pharmaceuticals packaging testing equipment encompasses instruments and systems used to verify the integrity, durability, sterility, and compliance of primary and secondary drug packaging materials including blister packs, … Read More
Published June 2026

South America Healthcare IoT Security Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 312.6 Million Market Size 2032: USD 894.3 Million CAGR: 14.1% Market Definition: The South America Healthcare IoT Security Market encompasses cybersecurity solutions — including network security, endpoint protection, cloud security, and identity management — deployed to protect internet-connected medical … Read More
Published June 2026

Wilson's Disease Drug Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 0.82 Billion Market Size 2034: USD 1.54 Billion CAGR: 6.5% Market Definition: The Wilson's Disease Drug Market encompasses pharmaceutical therapies used to treat Wilson's disease, a rare genetic disorder causing pathological copper accumulation in the liver, brain, and other … Read More
Published June 2026

Scleroderma Diagnostics Therapeutics Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 3.2 Billion Market Size 2034: USD 6.1 Billion CAGR: 6.7% Market Definition: The scleroderma diagnostics and therapeutics market encompasses tools for detecting systemic sclerosis — including autoantibody panels, imaging, and pulmonary function testing — alongside disease-modifying and symptomatic treatments … Read More
Published June 2026